Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07359742Recruiting
Detecting liver scarring in chronic liver disease
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
BrusselsAges 18 years+ - NCT07359768Recruiting
Testing a noninvasive device for heart disease risk
This trial uses a noninvasive device to examine small blood vessels in people at high risk for heart disease. It may help doctors better understand who needs preventive care.
Stockholm, DanderydAges Any age - NCT07360106Recruiting
Probiotic supplement for ongoing celiac symptoms
This trial tests if a daily probiotic drink (Symprove) can help people with celiac disease who still have stomach or gut symptoms even after following a strict gluten-free diet and having healed intestines.
Sheffield, South YorkshireAges 18–65 - NCT07361146Recruiting
Physical therapy during or before dialysis: a comparison
This study compares doing physical therapy during your dialysis session versus right before it. It looks at which timing might work better for people on hemodialysis.
HawalliAges 21–65 - NCT07362225Recruiting
MPN Progress Registry: Tracking Symptoms and Progression
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
Chicago, IllinoisAges 18 years+ - NCT07363044Recruiting
Biologic selection guided by epigenetic markers in Crohn's disease
This trial compares two different ways to choose your Crohn's treatment: one based on a special test of your cells (epigenetic markers) and the other based on standard care. It aims to see which approach works better for people with moderate to severe Crohn's disease.
AntwerpAges 18 years+ - NCT07363824Recruiting
Tear iron and dry eye severity study
This study looks at how iron levels in tears relate to the severity of dry eye disease. It aims to find a simple way to measure dry eye severity, which could help doctors better understand and treat the condition.
ShanghaiAges 18–70 - NCT07364734Recruiting
Study of hard-to-treat Crohn's disease
This study looks at people with Crohn's disease that is hard to treat. It aims to understand the disease better and see how well current treatments work.
Guangzhou, GuangdongAges 18–65 - NCT07365254Recruiting
Newborn whole genome sequencing for genetic disease risk
This study looks at using whole genome sequencing in newborns and families with ongoing pregnancies, including those conceived naturally or with fertility treatments. It aims to better understand and manage genetic disease risks early.
Hangzhou, ZhejiangAges Any age - NCT07365696Recruiting
Fatigue and brain fog after stem cell transplant
This trial looks at the causes of fatigue and cognitive problems (like memory or concentration issues) after a stem cell transplant. It uses old PET scans to study possible damage in the brain.
StockholmAges 20–75 - NCT07367815RecruitingPhase 1/Phase 2
Stem cells from fat tissue for Alzheimer's disease
This trial tests whether stem cells from donated fat tissue can help people with mild to moderate Alzheimer's disease. It combines infusions of these cells with standard care, and includes brain scans and memory tests to see if the treatment is safe and effective.
ToulouseAges 50–85 - NCT07367893Recruiting
Exercise echocardiogram registry for heart disease
This study is creating a registry (a database) of patients who have an exercise echocardiogram, which is a stress test that uses ultrasound to look at your heart during exercise. It aims to better understand and diagnose different types of heart disease.
Yongin, Gyeonggi-doAges 18 years+ - NCT07368933Recruiting
A drug-coated balloon for heart artery blockages
This trial tests a balloon coated with two drugs to treat narrowed or re-narrowed arteries in the heart. It may help people with chest pain or recent mild heart attacks who need a procedure to open a blockage.
BarcelonaAges 18 years+ - NCT07370532RecruitingPhase 2
Etoricoxib for Parkinson's disease
This study tests if etoricoxib, an anti-inflammatory drug, can help people with Parkinson's disease. You may join if you have a confirmed diagnosis and are not using other anti-inflammatory drugs.
Al MansurahAges 50–70 - NCT07372989RecruitingPhase 1
Inhaled amniotic fluid for lung scarring
This trial tests whether breathing in a mist of human amniotic fluid can help people with interstitial lung disease, a condition where lung tissue becomes scarred and stiff. It aims to see if this treatment is safe and might improve your breathing.
Venice, FloridaAges 18 years+ - NCT07374601Recruiting
Testing Super-Resolution Ultrasound for Peripheral Artery Disease
This study tests a new ultrasound technique that creates clearer images of blood vessels. It may help doctors better diagnose and understand peripheral artery disease, which affects blood flow to the legs.
Beijing, Beijing MunicipalityAges 18–100 - NCT07375433Recruiting
Heart failure and COPD study for patients aged 50 to 70
This trial looks at how heart failure with preserved pumping function affects people who also have COPD. It aims to understand the course of the disease and long-term outlook.
Kazan'Ages 50–70 - NCT07375940Recruiting
Understanding Behçet Disease in children and teens
This study looks at the health records and blood tests of children and young adults with Behçet disease to learn more about the condition. It also compares their results with healthy children to find clues that may help doctors better understand and treat Behçet disease.
Florence, FlorenceAges 6 months–70 years - NCT07376278Recruiting
Deep brain stimulation outcomes in Parkinson's disease
This study looks at factors that predict how well deep brain stimulation (DBS) works for people with Parkinson's disease. If you are considering DBS, joining this research could help doctors better understand who benefits most from the procedure.
Hong KongAges 18–75 - NCT07377188Recruiting
Pregnancy and Inflammatory Bowel Disease Study
This trial looks at how pregnancy affects and is affected by inflammatory bowel disease. It aims to learn more to help women with IBD who are or want to become pregnant.
AmiensAges 18–50 - NCT07378722Recruiting
Personalized music therapy for balance in Parkinson's disease
This study tests whether listening to personalized music can help improve balance and walking in people with Parkinson's. If you have mild balance issues and are between 45 and 55, this trial might be a good fit.
Lahore, Punjab ProvinceAges 45–55 - NCT07380204Recruiting
Measuring Hsp90 in the brain with a PET scan
This study uses a special PET scan to measure a protein called Hsp90 in the brain. It aims to understand how Hsp90 levels differ in healthy people and those with Parkinson's, Alzheimer's, or ALS, which may lead to new treatments.
Leuven, Vlaam-BrabantAges 18–70 - NCT07380737Recruiting
Walking Tall app for home exercise in Parkinson's
This study tests a smartphone app called Walking Tall that helps people with Parkinson's disease do walking exercises at home. It's looking for people who can walk on their own and are already in a specific rehab program.
Tel AvivAges 40–85 - NCT07381907Recruiting
Brain stimulation combined with Nordic walking for Parkinson's
This study combines a mild electrical brain stimulation (tDCS) with Nordic walking (walking with poles) to see if it helps improve walking and balance in people with Parkinson's disease. The treatment lasts 4 weeks and may be an option if you have a slow walking pace and no implanted brain devices.
Belém, ParáAges 50–75
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.